Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Insulin delivery by somatic cell gene therapy

C Stewart1, N A Taylor, K Docherty

  • 1Department of Pharmaceutical Sciences, Aston University, Birmingham, UK.

Journal of Molecular Endocrinology
|December 1, 1993
PubMed
Summary

Somatic cell gene therapy using transfected mouse pituitary cells demonstrated feasibility for insulin delivery in mice. This approach showed potential in delaying hyperglycemia in diabetic models.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Current Drug Treatment Landscape for Diabetes and Perspectives for the Future.

Clinical pharmacology and therapeutics·2015
Same author

Safety of antidiabetes medications: An update.

Clinical pharmacology and therapeutics·2015
Same author

Efficacy and safety of dapagliflozin monotherapy in people with Type 2 diabetes: a randomized double-blind placebo-controlled 102-week trial.

Diabetic medicine : a journal of the British Diabetic Association·2014
Same author

Pronounced reduction of postprandial glucagon by lixisenatide: a meta-analysis of randomized clinical trials.

Diabetes, obesity & metabolism·2014
Same author

A cotyledon slice system for the electron autoradiographic study of the synthesis and intracellular transport of the seed storage protein of Vicia faba.

Planta·2014
Same author

Dapagliflozin monotherapy in drug-naïve patients with diabetes: a randomized-controlled trial of low-dose range.

Diabetes, obesity & metabolism·2012

Area of Science:

  • Biotechnology
  • Gene Therapy
  • Endocrinology

Background:

  • Somatic cell gene therapy offers a potential alternative for insulin delivery.
  • Developing effective methods for sustained insulin production is crucial for diabetes management.

Purpose of the Study:

  • To investigate the feasibility of using gene-modified somatic cells for insulin delivery.
  • To assess the in vivo insulin release and therapeutic effect of transfected cells in a mouse model.

Main Methods:

  • Murine pituitary AtT20 cells were transfected with human preproinsulin DNA.
  • Selected cells (AtT20MtIns-1.4) were implanted into mice, which were subsequently induced into diabetes using streptozotocin.
  • Human insulin release was monitored via human C-peptide assays, and hyperglycemia was assessed.

Main Results:

  • Transfected cells released human insulin in vitro and in vivo.
  • Implanted cells formed tumor-like aggregations containing insulin.
  • The development of hyperglycemia was delayed in mice receiving insulin-releasing cells compared to controls.

Conclusions:

  • Somatic cell gene therapy is a feasible strategy for insulin delivery.
  • Gene-modified pituitary cells can be successfully implanted and function in vivo to produce insulin.
  • This approach shows promise for managing diabetes by providing a continuous source of insulin.

Related Experiment Videos